These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22329778)

  • 21. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
    Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
    Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient.
    Antony S
    Clin Infect Dis; 2004 Sep; 39(6):879-80. PubMed ID: 15472833
    [No Abstract]   [Full Text] [Related]  

  • 23. Emergence of Candida tropicalis resistant to caspofungin.
    Pasquale T; Tomada JR; Ghannoun M; Dipersio J; Bonilla H
    J Antimicrob Chemother; 2008 Jan; 61(1):219. PubMed ID: 18024953
    [No Abstract]   [Full Text] [Related]  

  • 24. Tzanck smear as an accurate and rapid diagnostic tool for cutaneous alternariosis in a renal transplant recipient.
    Karataş Toğral A; Güleç AT
    Clin Exp Dermatol; 2016 Oct; 41(7):747-50. PubMed ID: 27663148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of caspofungin increased dosage in a patient on rifampin-containing anti-tubercular treatment.
    Calcagno A; Baietto L; Pagani N; Bertucci R; Rostagno R; D'Avolio A; Di Perri G; De Rosa FG
    Scand J Infect Dis; 2013 Nov; 45(11):882-4. PubMed ID: 23796067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis.
    Spriet I; Meersseman W; Annaert P; de Hoon J; Willems L
    Eur J Clin Pharmacol; 2011 Jul; 67(7):753-5. PubMed ID: 21638033
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin.
    Ozkaya-Parlakay A; Tezer H; Kazmacan T; Gulhan B; Unal S
    J Trop Pediatr; 2014 Aug; 60(4):329-30. PubMed ID: 24567311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspofungin.
    Parakh A; Dubey AP; Samanta D
    Indian Pediatr; 2008 Nov; 45(11):905-10. PubMed ID: 19029563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Identification of Cutaneous Alternariosis in a Renal Transplant Patient.
    Schuermans W; Hoet K; Stessens L; Meeuwissen J; Vandepitte A; Van Mieghem A; Vandebroek K; Oris E; Coppens G
    Mycopathologia; 2017 Oct; 182(9-10):873-877. PubMed ID: 28656553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mucormycosis case treated with a combination of caspofungin and amphotericin B.
    Kazak E; Aslan E; Akalın H; Saraydaroğlu O; Hakyemez B; Erişen L; Yazıcı B; Gürcüoğlu E; Yılmaz E; Ener B; Helvacı S
    J Mycol Med; 2013 Sep; 23(3):179-84. PubMed ID: 23856448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality.
    Dignan FL; Evans SO; Ethell ME; Shaw BE; Davies FE; Dearden CE; Treleaven JG; Riley UB; Morgan GJ; Potter MN
    Bone Marrow Transplant; 2009 Jul; 44(1):51-6. PubMed ID: 19139735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis.
    Keir GJ; Garfield B; Hansell DM; Loebinger MR; Wilson R; Renzoni EA; Wells AU; Maher TM
    Thorax; 2014 Mar; 69(3):287-8. PubMed ID: 24029745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection.
    de Fabritiis P; Spagnoli A; Di Bartolomeo P; Locasciulli A; Cudillo L; Milone G; Busca A; Picardi A; Scimè R; Bonini A; Cupelli L; Chiusolo P; Olivieri A; Santarone S; Poidomani M; Fallani S; Novelli A; Majolino I
    Bone Marrow Transplant; 2007 Aug; 40(3):245-9. PubMed ID: 17529996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin.
    Doria C; Bodzin AS; Vaccino S; Daskalakis C; Krawitz S; Ramirez CB
    Clin Transplant; 2011; 25(4):569-75. PubMed ID: 20662881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous alternariosis microscopically mimicking blastomycosis.
    Osmond GW; Walters RW; Puri PK
    J Cutan Pathol; 2011 Nov; 38(11):923-5. PubMed ID: 21752048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Success of posaconazole therapy in a heart transplanted patient with Alternaria infectoria cutaneous infection.
    Rammaert B; Aguilar C; Bougnoux ME; Noël N; Charlier C; Denis B; Lecuit M; Lortholary O
    Med Mycol; 2012 Jul; 50(5):518-21. PubMed ID: 22142219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous infection with Alternaria triticina in a Bilateral lung transplant recipient.
    González-Vela MC; Armesto S; Unda-Villafuerte F; Val-Bernal JF
    Actas Dermosifiliogr; 2014 Oct; 105(8):e51-4. PubMed ID: 24440281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.
    Betts RF; Nucci M; Talwar D; Gareca M; Queiroz-Telles F; Bedimo RJ; Herbrecht R; Ruiz-Palacios G; Young JA; Baddley JW; Strohmaier KM; Tucker KA; Taylor AF; Kartsonis NA;
    Clin Infect Dis; 2009 Jun; 48(12):1676-84. PubMed ID: 19419331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective evaluation of caspofungin therapy in invasive aspergillosis (RECAM-IA).
    Wisniewski T; Klimko N; Laverdiere M; Kiertiburanakul S; Kliasova G; Trenschel R; Kumar RN
    Mycoses; 2011 Jul; 54(4):e148-53. PubMed ID: 20202110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.